Testagen

Testagen — Testes / Gonads Bioregulator

Testagen is a Khavinson-class short-chain bioregulator peptide that restores youthful gene expression in testes / gonads tissue.

Peptide Specifications

Parameter	Value
Sequence	Lys-Glu-Asp-Gly
Mass	419.4 g/mol
Purity	>98.0%
Target Organ	Testes / Gonads

Figure 1: Testagen Organ-Specific Bioregulation

Tissue-Specific Mechanism

1. Tetrapeptide with tropism for testicular Leydig and Sertoli cells.
2. Restores steroidogenic enzyme expression.
3. Normalizes endogenous testosterone synthesis.
4. Reverses testicular atrophy markers.
5. Resets HPG axis sensitivity.

Figure 2: Testes / Gonads Regeneration Curve

Research Results

• 1: Designed for male reproductive longevity.
• 2: Restores testosterone to younger ranges.
• 3: Gonadal preservation without HRT side effects.

Testicular Function Bioregulator

Testagen (Lys-Glu-Asp-Gly) is a synthetic tetrapeptide bioregulator derived from testicular tissue, targeting Leydig cell and Sertoli cell gene expression. Male reproductive function declines progressively with age: testosterone production decreases 1–2% annually after age 30, Leydig cell number declines, Sertoli cell efficiency drops, and spermatogenic output diminishes. Testagen addresses these changes at the transcriptional level by restoring gene expression patterns in testicular cells toward youthful profiles, supporting both endocrine (testosterone) and exocrine (spermatogenesis) testicular functions.

1. Testagen enters Leydig cell nuclei and modulates promoter accessibility for steroidogenic enzyme genes (StAR, CYP11A1, CYP17A1, 3β-HSD, 17β-HSD).
2. Steroidogenic acute regulatory protein (StAR) expression is normalized, restoring the rate-limiting step of cholesterol transport into mitochondria for testosterone synthesis.
3. LH receptor expression on Leydig cells is upregulated, improving sensitivity to pituitary gonadotropin signaling.
4. Sertoli cell gene expression (inhibin B, androgen-binding protein, transferrin) is restored, supporting the microenvironment for spermatogenesis.
5. Antioxidant defense in testicular tissue is enhanced, protecting steroidogenic enzymes and developing spermatocytes from oxidative damage.

Male Endocrine Research

• Late-Onset Hypogonadism: Testagen targets the age-related decline in testicular function that underlies late-onset hypogonadism, addressing the cause rather than supplementing the missing hormone.
• vs. TRT: Unlike testosterone replacement (which suppresses endogenous production via HPG axis feedback), Testagen aims to restore endogenous production capacity.
• Fertility: Sertoli cell support and spermatogenic gene normalization make Testagen relevant for age-related male subfertility research.
• Combination: Often combined with Prostamax (prostate bioregulator) for comprehensive male genitourinary aging protocols.
• Protocol: 1–2 capsules daily for 20–30 days. Courses repeated every 3–6 months. Compatible with concurrent HPG axis assessment.